I'm back in 1990

Chapter 953: The Launch of Pranoxetine

Damon then tried to smooth things over: "Alright, alright, my friends, tonight is a beautiful night. Although we are all in the middle of a huge storm, the most important thing for us now is to get through this storm together."

Damon's words essentially summed up the theme of the evening: his hope for deeper collaboration with Zhang Sui and her team, given their undeniable achievements.

Wall Street elites know that in the current liquidity crunch, those who hold large amounts of cash are kings, and Zhang Sui is one such king who holds a large amount of cash.

Following up on Dimon's words, Zhang Sui stated: "We have always been open to high-quality opportunities. In fact, we are already evaluating the assets of several regional banks and are preparing to make strategic investments at the appropriate time."

Zhang Sui's words immediately attracted everyone's attention. At a time when the financial system was on the verge of collapse, Zhang Sui was actually going to make contrarian investments. Generally speaking, this situation is either crazy or she saw an opportunity that others did not see.

After the banquet, Zhang Sui, escorted by bodyguards, got into a Cadillac armored sedan and instructed the driver, "Back to the office."

A small convoy of three cars drove along the streets of New York City toward Midtown, the neon lights still gleaming on both sides of the road.

Zhang Sui understood that she and her team might be experiencing a major historical event, and that her name might be recorded in history.

Back in her office, her secretary, Emilia, was still at her post.

"Boss! We have another message from the Finance Ministry. Secretary Paulson wants to see you on Monday. I've noted down the time and place."

Zhang Sui nodded and continued walking briskly towards her office. Emilia quickly stepped forward and opened the door.

After Zhang Sui sat down, Emilia continued her report: "As planned, we reduced the remaining 12% of our CDS positions today, and the two investment banks that took over were quite satisfied with the price."

Zhang Sui nodded: "Very good!"

This was also part of the previous plan. They would only take a portion of the final CDS revenue and leave some for the next investors. However, not just anyone was qualified to take over; only Changhong Capital's partners were eligible. This conveyed the message that Changhong Capital was willing to share the profits with its partners.

Later on Monday, Zhang Sui had an informal coffee shop meeting with Finance Minister Paulson, during which Zhang Sui hinted that she and her team were willing to cooperate with the government's next steps.

However, this was not unconditional. Paulson naturally reciprocated by agreeing to some of the conditions proposed by Zhang Sui, and both sides were very satisfied with the outcome of this informal meeting.

Following that, Zhang Sui reached some cooperation agreements with several major investment banks with certain conditions. Of course, Zhang Sui was the one who proposed the conditions. At this time, Zhang Sui was already quite generous, so there were no obstacles to the cooperation and the agreements were reached smoothly.

As a result, Zhang Sui and her team received support from regulators, which was one of the rewards.

In addition, Zhang Sui also accepted an exclusive interview with BC, where she provided a comprehensive analysis of the crisis with an objective, calm, and professional evaluation. She explained that she and her team made their judgments based on publicly available data analysis and carried out a series of subsequent operations. It was precisely because they won their gamble that she appeared on the television interview program. If she and her team had failed, no one would remember them, and they would have been swept into the sewers like the vast majority of losers on Wall Street.

Every word Zhang Sui said was carefully considered. She understands American society very well. If there were any loopholes in her words, it might attract an investigation by the SEC, a hearing in Congress, or worse, make her an enemy of the entire nation.

The interview had a very good effect, changing the public's perception of them. Previously, according to the survey, a considerable proportion of respondents believed that Dark Night Capital was a vulture that came to take advantage of the situation. After the interview was broadcast, everyone was convinced.

Dark Night Capital's success was based on risky behavior driven by data analysis, which was extremely risky, but they won the gamble, which is acceptable to American society.

Just as Zhang Sui was extremely busy, KRB01 was officially approved for production and sales in China. It should be noted that once this door was opened, the encirclement previously formed by several global pharmaceutical giants would be broken.

The logic is simple: once patients know that this miraculous drug exists, they will definitely try every means to obtain it. In this way, the barriers created by the authorities' refusal to approve or their deliberately raised approval standards will be broken down.

No one can ignore the needs and anger of millions of patients around the world.

Therefore, Xie Xinyue became even busier, and Yu Xiang was also extremely busy. Not long ago, Huang Xiaochuan instructed Cao Charlie to spin off Kerui Pharmaceutical from Dadao Group and form Hong Kong Kerui Pharmaceutical Group. 85% of the shares were transferred to offshore companies registered in the Cayman Islands and other places under Yu Xiang's name, while the remaining shares were used as stock options to incentivize researchers and management.

Xie Xinyue acquired a 2% stake in the newly formed Kerui Pharmaceutical Group.

The approval of KRB01 immediately shook the entire pharmaceutical industry.

The phone in Xie Xinyue's office never stopped ringing, keeping her secretary extremely busy.

One minute it's an interview request from an international medical journal, the next it's the confirmation form for the first batch of drug production processes from the production department, and then it's some domestic drug research and development experts coming to learn from us.

Yu Xiang's job wasn't easy either; her office at Kangci Hospital also became the chairman's office of Hong Kong Kerui Pharmaceutical Group.

The secretary was reporting to her: "Chairwoman Yu, a representative from the European Medicines Agency would like to schedule a call with you, mainly regarding expediting the approval of KRB01."

Yu Xiang rubbed her temples: "Let's schedule it for 10 a.m. tomorrow!" She had been working non-stop these past few days, and although she was tired, she felt a great sense of accomplishment.

Especially since she had seen many patients with such helpless expressions when she was a doctor, she was the one who most hoped that this drug could be launched on the market as soon as possible.

After such a long period of research and development and clinical trials, it has finally obtained the market approval. She has also contributed a lot to this. Her husband provided the money, and she provided the labor. The two of them have done a lot for this drug.

A few days later, the first batch of KRB01 was introduced into several top-tier hospitals in China. After its market launch, KRB01 was named "Liconxi".